Core Framework & Diagram How Do Bacteria Evade the Immune System?
7 月 27, 20261 Min Read How Do Fungi Evade the Immune System?
7 月 27, 2026Bacteria have their own diverse set of immune evasion strategies
—— Mycobacterium tuberculosis can live inside your immune cells for decades — the molecular mechanisms behind this are remarkable.
I. Bacteria don't just develop antibiotic resistance — they also 'evade immunity'
When we discuss the challenges of bacterial infection, most people think of antibiotic resistance — superbugs, MRSA, carbapenem-resistant bacteria. Resistance is certainly a serious problem, detailed in Article 42.
But resistance is only part of the strategies bacteria developed to survive in humans. Another equally important but less-discussed strategy is immune evasion — bacteria use various molecular mechanisms to evade immune system recognition, phagocytosis, or killing, establishing persistent infections in hosts.
These two strategies (resistance and immune evasion) are independent and can overlap: a bacterium can both be antibiotic-resistant (evading drug killing) and evade immune system recognition (evading host defenses). When these two capacities combine, the most difficult infection scenarios arise.
Understanding bacterial immune evasion strategies has several important practical implications: it explains why certain bacterial infections (tuberculosis, brucellosis, some Salmonella infections) become chronic or recurrent; it reveals why for some bacterial infections antibiotics alone are insufficient, requiring simultaneous reinforcement of cellular immune responses; and it provides clues for vaccine design — immune targets against bacterial evasion mechanisms are often more effective than vaccines targeting conventional surface antigens.
2. Capsule: the bacteria's 'invisibility cloak' making phagocytes struggle to attack
The capsule is a polysaccharide outer layer wrapping many bacteria's cell wall exterior. From the bacterium's perspective, the capsule is an extremely clever evasion tool, simultaneously countering multiple immune clearance mechanisms.
Blocking complement activation
C3b is the key opsonization molecule — under normal conditions, depositing in large amounts on bacterial surfaces through alternative or classical pathways, 'labeling' bacteria for phagocytes and dramatically improving phagocytic efficiency. The capsule's presence covers the bacterial surface with a polysaccharide shell that prevents C3b from directly contacting bacterial surface proteins and lipopolysaccharides, preventing effective complement activation and deposition.
Physically impeding phagocyte pseudopod adhesion
The first step of phagocytosis requires phagocyte pseudopods to firmly contact the target surface for recognition receptors to effectively bind. The capsule's polysaccharide shell makes phagocyte pseudopods unable to stably contact bacterial surface receptors, dramatically reducing direct phagocytosis efficiency.
Why specific antibodies are essential
Most critically: capsules make bacteria nearly impossible to phagocytose effectively without specific antibody assistance. With specific IgG antibodies against particular capsular polysaccharide types (whether established through natural infection or vaccination), IgG's Fab ends bind to the capsule polysaccharide while Fc ends are exposed, recruiting phagocyte Fc receptors and penetrating the capsule 'barrier,' allowing phagocytic efficiency to return to normal levels.
This is exactly why pneumococcal vaccines (PCV and PPV) cover as many serotypes' capsular polysaccharides as possible — vaccination essentially pre-builds a 'key collection' for multiple capsule types, allowing the immune system to immediately initiate efficient opsonic phagocytic clearance when encountering these bacteria rather than starting from zero.
3. SMycobacterium tuberculosis: making a home inside macrophages, preventing lysosome fusion forever
Mycobacterium tuberculosis (Mtb) is the ultimate master of bacterial immune evasion. Its strategy isn't 'avoid being engulfed' — it's 'not being digested after being engulfed.' It converts what should eliminate it into its own safe home.
The normal phagocytosis flow: bacteria engulfed by macrophage → phagosome forms → phagosome progressively matures (pH gradually drops from 7.4 to 4.5) → lysosome fuses with phagosome (forming phagolysosome) → 50+ hydrolases activated → bacteria completely digested.
Mycobacterium tuberculosis precisely disrupts the most critical step in this flow: phagosome-lysosome fusion.
Mtb's core evasion molecule is lipoarabinomannan (LAM). LAM disrupts phosphatidylinositol-3-phosphate (PI3P) signaling by inserting into the phagosome membrane. PI3P is the lipid signaling molecule essential for phagosome maturation and lysosome fusion — without PI3P, the phagosome can't complete the maturation transition from 'early endosome' to 'late phagosome,' and permanently stays in a mildly acidic (pH ~6.4), lysosomal enzyme-deficient 'safe room,' unable to fuse with lysosomes.
In this mildly acidic phagosome, Mtb can safely survive, even slowly reproducing. Furthermore, Mtb can secrete more effector proteins from this phagosome 'cozy sanctuary,' actively modifying the phagosome membrane composition, further consolidating this stable state of not being digested.
Clearing this intracellularly residing tuberculosis depends on IFN-γ from Th1-type T cells. IFN-γ-activated macrophages (M1 type) force phagosome maturation through multiple mechanisms (enhancing PI3P signaling, upregulating lysosomal enzyme expression, enhancing NADPH oxidase ROS production), partially overcoming Mtb's evasion mechanism. This is why tuberculosis treatment and immunity must depend on strong cellular immunity (Th1-type CD4+ T cells plus activated macrophages) — not just antibodies.
4. Listeria and Salmonella: different escape routes, different costs
Listeria monocytogenes
A food-borne pathogen that contaminates food (particularly refrigerated meats and soft cheeses), capable of causing serious bacteremia and meningitis in pregnant women, older adults, and immunocompromised individuals. Listeria's evasion strategy is completely different from Mycobacterium tuberculosis: rather than preventing digestion, it actively lyses the phagosome membrane after engulfment and escapes into the cytoplasm.
Its 'jailbreak tool' is listeriolysin O (LLO), a perforin specifically activated at acidic pH (the mildly acidic environment inside phagosomes). LLO punches holes in the phagosome membrane, allowing the bacterium to escape into the cytoplasm. Once in the cytoplasm, Listeria uses another trick: recruiting the host cell's actin to polymerize on its own surface, forming an actin 'tail' that uses actin polymerization's pushing force to move rapidly inside the cell, and can directly push into adjacent cells, achieving cell-to-cell spread. The entire process doesn't need to pass through the extracellular environment — completely evading blood-borne antibodies and complement. This 'actin propulsion' movement mode means Listeria infection can't be blocked by antibodies — CD8+ T cells and NK cells are needed to clear infected cells.
Salmonella
Salmonella's evasion mode differs again: after being engulfed, it doesn't try to escape the phagosome. Instead it actively remodels its phagosome, forming a 'Salmonella-containing vacuole' (SCV). Through secreting effector proteins (via type III secretion system), it reprograms the host cell's vesicle transport pathway, preventing SCV fusion with lysosomes while acquiring host cell nutrients, continuing to reproduce within the SCV.
5. What bacterial immune evasion teaches us: why cellular immunity is critical for certain infections
Understanding these bacterial immune evasion strategies, an important conclusion becomes very clear: for bacteria capable of surviving intracellularly (intracellular bacteria), antibodies and complement are extremely limited — effective defense must depend on cellular immunity (CD4+ T cells, CD8+ T cells, and activated macrophages).
Why? Because once bacteria enter cells, they escape direct contact with blood-borne antibodies and complement. Antibodies can't cross cell membranes to neutralize intracellular bacteria; complement opsonization requires bacteria to be exposed extracellularly. In intracellular bacterial infections, only through cellular immunity — CD4+ T cells secreting IFN-γ to activate macrophages (forcing M1 macrophages to complete phagosome maturation), CD8+ T cells recognizing MHC-I presentations of infected cells and killing them (releasing intracellular bacteria to be exposed to antibodies and neutrophils) — can infection be effectively controlled and cleared.
This is why AIDS patients (CD4+ T cells depleted by HIV) are particularly susceptible to tuberculosis, Salmonella bacteremia, and other intracellular bacterial infections — they lack the core signaling molecule for activating macrophages. This is also why BCG (Bacillus Calmette-Guérin, tuberculosis vaccine) protection mechanism primarily works through building strong Th1-type CD4+ T cell memory against tuberculosis antigens — not building neutralizing antibodies.
For people over forty, these mechanisms have practical significance: Th1-type cellular immunity declines with age (CD4+ T cells' IFN-γ production capacity weakening) — this is a core immunological reason why tuberculosis reactivation risk rises in older adults. Maintaining good T cell function (regular exercise, adequate sleep, controlling chronic stress), plus regular tuberculosis screening for high-risk populations, are important strategies for preventing tuberculosis reactivation in older adults.
Frequently Asked Questions